Arab Journal of Gastroenterology
Volume 12, Issue 3 , Pages 125-130 , September 2011

A clinical study of Wilson’s disease: The experience of a single Egyptian Paediatric Hepatology Unit

  • Hanaa El-Karaksy

      Affiliations

    • Pediatrics Department, Cairo University, Cairo, Egypt
    • Corresponding Author InformationCorresponding author. Address: 44 Mohei El-Deen Abu El-Ezz Street, Dokki, Cairo 12311, Egypt. Tel.: +20 2 33375913 (office), +20 2 37601652 (home); fax: +20 22 5311616.
  • ,
  • Mona Fahmy

      Affiliations

    • Pediatrics Department, Research Ophthalmology Institute, Cairo, Egypt
  • ,
  • Mona S. El-Raziky

      Affiliations

    • Pediatrics Department, Cairo University, Cairo, Egypt
  • ,
  • Manal El-Hawary

      Affiliations

    • Pediatrics Department, Fayoum University, Fayoum, Egypt
  • ,
  • Rokaya El-Sayed

      Affiliations

    • Pediatrics Department, Cairo University, Cairo, Egypt
  • ,
  • Nehal El-Koofy

      Affiliations

    • Pediatrics Department, Cairo University, Cairo, Egypt
  • ,
  • Fatma El-Mougy

      Affiliations

    • Chemical Pathology Department, Cairo University, Cairo, Egypt
  • ,
  • Ahmad El-Hennawy

      Affiliations

    • Pathology Department, Cairo University, Cairo, Egypt
  • ,
  • Mortada El-Shabrawi

      Affiliations

    • Pediatrics Department, Cairo University, Cairo, Egypt

Received 2 May 2011 ,Accepted 28 July 2011.

References 

  1. Schilsky ML. Diagnosis and treatment of Wilson’s disease. Pediatr Transplant. 2002;6:15–19
  2. Weiss KH, Lozoya JC, Tuma S, Gotthardt D, Reichert J, Ehehalt R, et al. Copper-induced translocation of the Wilson disease protein ATP7B independent of Murr1/COMMD1 and Rab7. Am J Pathol. 2008;173(6):1783–1794[Epub 2008 October 30]
  3. Majumdar R, Al Jumah M, Fraser M. 4193delC, a common mutation causing Wilson’s disease in Saudi Arabia: rapid molecular screening of patients and carriers. Mol Pathol. 2003 Oct;56(5):302–304
  4. Abdelghaffar TY, Elsayed SM, Elsobky E, Bochow B, Büttner J, Schmidt H. Mutational analysis of ATP7B gene in Egyptian children with Wilson disease: 12 novel mutations. J Hum Genet. 2008;53(8):681–687[Epub 2008 May 16]
  5. Frydman M. Genetic aspects of Wilson’s disease. J Gastroenterol Hepatol. 1990;5:483–490
  6. Saito T. Presenting symptoms and natural history of Wilson disease. Eur J Pediatr. 1987;146:261–265
  7. Roberts EA, Schilsky ML. Diagnosis and treatment of Wilson disease: an update. Hepatology. 2008;47:2089–2111
  8. Dhawan A, Taylor RM, Cheeseman P, De Silva P, Katsiyiannakis L, Mieli-Vergani G. Wilson’s disease in children: 37-year experience and revised King’s score for liver transplantation. Liver Transpl. 2005;11:441–448
  9. da Costa D, Baldwin D, Portmann B, Lolin Y, Mowat AP, Mieli-Vergani G. Value of urinary copper excretion after penicillamine challenge in the diagnosis of Wilson’s disease. Hepatology. 1992;15:609–615
  10. Ferenci P, Caca K, Loudianos G, Mieli-Vergani G, Tanner S, Sternlieb I, et al. Diagnosis and phenotypic classification of Wilson disease. Liver Int. 2003;23:139–142
  11. Medici V, Trevisan CP, D’Incà R, Barollo M, Zancan L, Fagiuoli S, et al. Diagnosis and management of Wilson’s disease: results of a single center experience. J Clin Gastroenterol. 2006;40:936–941
  12. Jha SK, Behari M, Ahuja GK. Wilson’s disease: clinical and radiological features. J Assoc Physicians India. 1998;46:602–605
  13. Taly AB, Meenakshi-Sundaram S, Sinha S, Swamy HS, Arunodaya GR. Wilson disease description of 282 patients evaluated over 3 decades. Medicine. 2007;82:112–121
  14. Maier-Dobersberger T, Ferenci P, Polli C, Balać P, Dienes HP, Kaserer K, et al. Detection of the His1069Gln mutation in Wilson disease by rapid polymerase chain reaction. Ann Intern Med. 1997;127:21–26
  15. Wang XH, Cheng F, Zhang F, Li XC, Kong LB, Li GQ, et al. Living related liver transplantation for Wilson’s disease. Transpl Int. 2005;18:651–656
  16. Merle U, Schaefer M, Ferenci P, Stremmel W. Clinical presentation, diagnosis and long-term outcome of Wilson’s disease: a cohort study. Gut. 2007;56:115–120
  17. Schilsky ML. Identification of the Wilson’s disease gene: clues for disease pathogenesis and the potential for molecular diagnosis. Hepatology. 1994;20:529–533
  18. Markiewicz-Kijewska M, Szymczak M, Ismail H, Prokurat S, Teisseyre J, Socha P, et al. Liver transplantation for fulminant Wilson’s disease in children. Ann Transplant. 2008;13:28–31
  19. Kasai N, Miyoshi I, Osanai T, Yamashita T, Kamimura E, Yoshida MC. Effects of sex hormones on fulminant hepatitis in LEC rats: a model of Wilson’s disease. Lab Anim Sci. 1992;42:363–368
  20. Sternlieb I. Perspectives on Wilson’s disease. Hepatology. 1990;12:1234–1239
  21. Roberts EA, Schilsky ML. A practice guideline on Wilson disease. Hepatology. 2003;37:1475–1492
  22. Gibbs K, Walshe JM. A study of the caeruloplasmin concentrations found in 75 patients with Wilson’s disease, their kinships and various control groups. Q J Med. 1979;48:447–463
  23. Stremmel W, Meyerrose KW, Niederau C, Hefter H, Kreuzpaintner G, Strohmeyer G, et al. Wilson disease: clinical presentation, treatment, and survival. Ann Intern Med. 1991;115:720–726
  24. Schilsky ML, Sternlieb I. Overcoming obstacles to the diagnosis of Wilson’s disease. Gastroenterology. 1997;113:350–353
  25. Walshe JM. Wilson’s disease presenting with features of hepatic dysfunction: a clinical analysis of eighty-seven patients. Q J Med. 1989;70:253–263
  26. Lau JY, Lai CL, Wu PC, Pan HY, Lin HJ, Todd D. Wilson’s disease: 35years’ experience. Q J Med. 1990;75:597–605
  27. Giacchino R, Marazzi MG, Barabino A, Fasce L, Ciravegna B, Famularo L, et al. Syndromic variability of Wilson’s disease in children. Clinical study of 44 cases. Ital J Gastroenterol Hepatol. 1997;29:155–161
  28. Sanchez-Albisua I, Garde T, Hierro L, Camarena C, Frauca E, de la Vega A, et al. A high index of suspicion: the key to an early diagnosis of Wilson’s disease in childhood. J Pediatr Gastroenterol Nutr. 1999;28:186–190
  29. Demirkiran M, Jankovic J, Lewis RA, Cox DW. Neurologic presentation of Wilson disease without Kayser–Fleischer rings. Neurology. 1996;46:1040–1043
  30. Steindl P, Ferenci P, Dienes HP, Grimm G, Pabinger I, Madl C, et al. Wilson’s disease in patients presenting with liver disease: a diagnostic challenge. Gastroenterology. 1997;113:212–218
  31. Dunn LL, Annable WL, Kliegman RM. Pigmented corneal rings in neonates with liver disease. J Pediatr. 1987;110:771–776
  32. Zargar SA, Thapa BR, Sahni A, Mehta S. Kayser–Fleischer like ring in autoimmune chronic active hepatitis. Indian J Gastroenterol. 1991;10(3):101–102
  33. Müller T, Koppikar S, Taylor RM, Carragher F, Schlenck B, Heinz-Erian P, et al. Re-evaluation of the penicillamine challenge test in the diagnosis of Wilson’s disease in children. J Hepatol. 2007;47:270–276
  34. Roberts EA, Jimenez C, O’Connor C, Cox DW. Diagnosis and outcome of Wilson disease in a paediatric cohort [Abstract]. J Pediatr Gastroenterol Nutr. 2004;39(Suppl 1):A128
  35. Scott J, Gollan JL, Samourian S, Sherlock S. Wilson’s disease, presenting as chronic active hepatitis. Gastroenterology. 1978;74:645–651
  36. Schilsky ML, Scheinberg IH, Sternlieb I. Prognosis of Wilsonian chronic active hepatitis. Gastroenterology. 1991;100:762–767
  37. Milkiewicz P, Saksena S, Hubscher SG, Elias E. Wilson’s disease with superimposed autoimmune features: report of two cases and review. J Gastroenterol Hepatol. 2000;15:570–574
  38. Yener S, Akarsu M, Karacanci C, Sengul B, Topalak O, Biberoglu K, et al. Wilson’s disease with coexisting autoimmune hepatitis. J Gastroenterol Hepatol. 2004;19:11–114
  39. Iorio R, D’Ambrosi M, Marcellini M, Barbera C, Maggiore G, Zancan L, et al. Persistence of elevated aminotransferase in Wilson’s disease despite adequate therapy. Hepatology. 2004;39:1173–1174
  40. Durand F, Bernuau J, Giostra E, Mentha G, Shouval D, Degott C, et al. Wilson’s disease with severe hepatic insufficiency: beneficial effects of early administration of d-penicillamine. Gut. 2001;48:849–852
  41. Pellecchia MT, Criscuolo C, Longo K, Campanella G, Filla A, Barone P, et al. Clinical presentation and treatment of Wilson’s disease: a single-centre experience. Eur Neurol. 2003;50:48–52
  42. Iorio R, D’Ambrosi M, Marcellini M, Barbera C, Maggiore G, Zancan L, et al. Serum transaminases in children with Wilson’s disease. J Pediatr Gastroenterol Nutr. 2004;39:331–336
  43. DuBois RS, Rodgerson DO, Martineau G, Shroter G, Giles G, Lilly J, et al. Orthotopic liver transplantation for Wilson’s disease. Lancet. 1971;1:505–508
  44. El-Karaksy H, Nomachi S, Esmat G, El-Serafy M, Kamel R, El-Ansary A, et al. Equal outcome of living-related liver transplantation for Wilson’s disease from heterozygote and non-heterozygote donors: a report of a brother and sister. Indian J Med Sci. 2007;61:286–288
  45. Manolaki N, Nikolopoulou G, Daikos GL, Panagiotakaki E, Tzetis M, Roma E, et al. Wilson disease in children: analysis of 57 cases. J Pediatr Gastroenterol Nutr. 2008;48:72–77
  46. Walshe JM. Diagnosis and treatment of presymptomatic Wilson’s disease. Lancet. 1988;2:435–437
  47. Brewer GJ, Dick RD, Yuzbasiyan -Gurkan V, Johnson V, Wang Y. Treatment of Wilson’s disease with zinc. XIII: therapy with zinc in presymptomatic patients from the time of diagnosis. J Lab Clin Med. 1994;123:849–858

PII: S1687-1979(11)00080-3

doi: 10.1016/j.ajg.2011.07.007

Arab Journal of Gastroenterology
Volume 12, Issue 3 , Pages 125-130 , September 2011